Skip to content

The effect of svf in periorbital rejuvenation

Investigating the effect of stromal vascular fraction gel (svf+non cross-linked hyaluronic acid)on the periorbital rejuvenation and comparig it with svf injection alone

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220322054341N3
Enrollment
10
Registered
2025-10-22
Start date
2025-09-22
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

periorbital aging/wrinkles/hyperpigmentation. Other melanin hyperpigmentation

Interventions

Intervention 1: Intervention group: Intervention Group 1: Injection of 2 cc stromal vascular fraction (SVF) cells extracted from abdominal fat into one side of the periocular area. Fat harvesting inv

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: participants aged 20 to 65 years presenting with age-related periorbital changes (including dark circles, periorbital wrinkles, decreased skin firmness, and under-eye laxity), who provide informed consent and are able to attend follow-up visits, will be included in the study.

Exclusion criteria

Exclusion criteria: Active inflammation or herpetic infection at the procedure site, collagen vascular diseases, or warts use of corticosteroids, immunosuppressive, anticoagulant, or antiplatelet medications platelet function disorders or thrombocytopenia pregnancy or lactation

Design outcomes

Primary

MeasureTime frame
Pigmentation (color of the lesion). Timepoint: 1 and 3 months after the treatment. Method of measurement: Skin analysis using the VisioFace system/Patient satisfaction (Patient Global Assessment Score/Physician satisfaction (Physician Global Assessment Score.;Wrinkle. Timepoint: 1 and 3 months after the treatment. Method of measurement: Skin analysis using the VisioFace system/Patient satisfaction (Patient Global Assessment Score/Physician satisfaction (Physician Global Assessment Score.

Secondary

MeasureTime frame
Complications. Timepoint: 1 and 3 months after the treatment. Method of measurement: Using a checklist containing treatment complications including pain, erythema and edema.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoumeh Roohaninasab

Iran University of Medical Sciences

rohaninasab.m@iums.ac.ir+98 21 8871 7272

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026